Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-07-14FDA Approved: LOPID — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Lopid (gemfibrozil) filed by the Parke-Davis division of Pfizer Inc. The action updates the …
-
CLINICAL_TRIALS research · 2009-07-08Clinical Trial Update: Triglyceride Lowering Study [Phase 4]
A Phase 4 clinical trial studying triglyceride-lowering therapy for hypertriglyceridemia sponsored by Jewish Hospital, Cincinnati; current s…
-
CLINICAL_TRIALS trial_result · 2009-05-12Clinical Trial Update: Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Omacor co-administered with atorvastatin in hypertriglyceridemia completed with posted r…
-
FDA approval · 2009-04-20FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2009-03-30Clinical Trial Update: Effect of Omacor on Triglycerides in HIV Infected Subjects [Phase 4]
This Phase 4 trial update reports the terminated study evaluating Omacor on triglyceride levels in HIV-infected subjects with hypertriglycer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides [Phase 1]
Phase 1 clinical trial assessing the effect of Gemfibrozil on serum GPI phospholipase D and triglycerides in individuals with hypertriglycer…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Regulation of Sterol Homeostasis
The clinical trial investigating the regulation of sterol homeostasis for hypertriglyceridemia has completed.
-
FDA approval · 2008-12-15FDA Approved: FENOFIBRIC ACID — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved fenofibric acid under an Original Application by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2008-12-12FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc., authorizing an update to the produ…
-
CLINICAL_TRIALS trial_result · 2008-09-03Clinical Trial Update: Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients [Phase 4]
Phase 4 clinical trial evaluating the effects of fenofibrate on adipocytokine levels in patients with hypertriglyceridemia.
-
CLINICAL_TRIALS trial_result · 2008-08-08Clinical Trial Update: Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides [NA]
A completed clinical trial evaluated docosahexaenoic acid (DHA) supplementation for cardiovascular outcomes in men with high triglycerides.
-
FDA approval · 2008-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for fenofibrate.
-
FDA approval · 2008-03-26FDA Approved: FENOFIBRATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's generic fenofibrate (ANDA 076509) as an original application, establishing equivalence to the r…
-
CLINICAL_TRIALS trial_result · 2008-03-11Clinical Trial Update: Pharmacological Regulation of Fat Transport in Metabolic Syndrome [Phase 4]
Phase 4 clinical trial update on pharmacological regulation of fat transport in metabolic syndrome; the study has completed.
-
FDA approval · 2007-12-06FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides [Phase 3]
A Phase 3 trial comparing torcetrapib/atorvastatin versus atorvastatin alone in patients with high triglycerides has completed.
-
FDA approval · 2007-11-07FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2007-06-12FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2007-02-01FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2006-07-27FDA Approved: GEMFIBROZIL — Original Application (Exelan Pharmaceuticals, Inc.)
FDA approved the original application for a generic Gemfibrozil by Exelan Pharmaceuticals, enabling a generic version of Gemfibrozil to be m…